Cramer's lightning round: Don't touch this pharma play

Jim Cramer rattles off his take on callers' favorite stocks, including that of one controversial pharmaceutical company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.